# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-30T16:40:59.557526

---

**Idea Fidelity**

The paper hews closely to the original manifest. It maintains the core research question—whether late transposition of EU directives (“limbo”) suppresses firm entry—uses the suggested CELLAR transposition data and Eurostat business demography panel, and exploits within-directive timing variation across member states. The empirical design broadly matches the stated identification strategy, although the completed paper narrows the sectoral scope to three broad NACE sections (Trade, Transport, Finance) rather than the more extensive panel of 1,250 NUTS3 × 11 sectors mentioned in the manifest. This restriction is acknowledged in the data section, so the paper does not deviate in spirit, but it does reduce the coverage and variation envisioned initially.

**Summary**

This paper investigates the economic cost of EU directive transposition delays by linking CELLAR implementation dates to Eurostat firm birth data. Using country-sector-year panel data and a two-way fixed effects model, the author finds that sectors affected by a directive in “limbo” experience a 21.5% decline in new registrations, particularly in heavily regulated sectors (finance, energy, health, transport). The claim is that regulatory uncertainty during the implementation gap—rather than the substance of the directive—drives entrepreneurs to delay entry.

**Essential Points**

1. **Identification is underspecified.** The empirical model aggregates treatment at the sector-year level but does not explicitly account for directive-level timing beyond the limbo indicator. Because multiple directives vary in their delay status over time, the model should control for directive-by-year (or at least directive-by-period) shocks to isolate the effect of delay from contemporaneous sector-wide shocks that happen to coincide with limbo. In its current form, a general slowdown in a sector (say due to a sector-specific aggregate shock) that also affects the probability of delay in certain countries could be spuriously attributed to limbo. An event-study or a set of leads and lags for limbo would help demonstrate parallel trends and isolate the timing of the effect.

2. **Measurement of sectoral exposure is imprecise.** The treatment indicator flags whether *any* directive affecting a broad NACE section is in limbo, yet a directive might target a small subset of subsectors or be largely irrelevant for most firms in the section. Without a convincing mapping from directives to the precise industries in the outcome data, measurement error may be severe and could bias the estimates in either direction. The robustness checks (e.g., placebo sectors) are not yet shown, and the reliance on broad NACE sections raises doubts about whether the observed reduction in firm births truly reflects directive-induced uncertainty rather than coincidental sectoral dynamics.

3. **Mechanism and confounders need tighter examination.** Countries that systematically delay (or accelerate) transposition may differ in time-varying ways—economic capacity, enforcement priorities, institutional shocks—which also influence firm entry. The paper mentions dropping late transposers and leave-one-out checks, but more is needed: for example, controlling for country-level economic conditions (GDP growth, credit access) or directive-specific urgency, and showing that director-specific shocks do not drive both delay and firm births. Otherwise, the negative coefficient could reflect endogenous delays during downturns rather than limbo-induced uncertainty.

If these issues cannot be convincingly resolved, the paper risks rejection.

**Suggestions**

1. **Strengthen the identification and add diagnostics.**  
   - Include directive-year or directive-country-year fixed effects (as feasible) so that the variation comes explicitly from within-directive variation in delay, rather than sector-wide trends. At minimum, show that the timing of limbo is orthogonal to pre-trends by estimating an event-study with several leads and lags of the limbo indicator.  
   - Report placebo tests more explicitly (e.g., sectors supposedly unaffected by a directive) and show that event-time estimates are flat before treatment and disappear in non-targeted sectors.  
   - Confirm that countries are not entering limbo periods systematically during national downturns by regressing limbo on contemporaneous macro controls (GDP, investment, credit growth) and showing the coefficients are small.

2. **Improve the treatment mapping.**  
   - Discuss in more detail how directives are assigned to sectors. Is it based solely on EUR-Lex subject codes, or are keywords used? Consider validating the mapping with manual checks on a subset of directives or by linking to more granular NACE sub-sectors when possible.  
   - Report how many directives are actually relevant to each of the three NACE sections and whether the treatment varies enough within each sector-year to identify effects.  
   - If possible, exploit differences in directive scope by constructing weighted exposure measures (e.g., weighting directives by the share of sectoral employment they cover) to reduce attenuation.

3. **Broaden and contextualize robustness.**  
   - The Callaway–Sant’Anna results are puzzlingly opposite in sign. Rather than dismissing them as noise from measurement error, engage more fully: what cohorts drive the positive effect? Does it disappear once the cohort definition matches the TWFE sample?  
   - Explore potential heterogeneous mechanisms beyond broad regulatory categories. For example, does the effect differ for directives with large anticipated compliance costs versus more procedural directives?  
   - If data allow, add controls for enforcement or administrative capacity (e.g., number of transposition staff, legal backlog), to ensure that limbo is not proxying for governance quality.

4. **Clarify data limitations and implications.**  
   - The paper is transparent about only covering 20 member states and three sectors, but it could better explain how representative these are of the broader EU economy. Are the affected sectors more prone to regulation changes, or are they chosen because of data availability?  
   - The discussion could benefit from extrapolating the aggregate economic cost of firm entry suppression (e.g., applied to EUwide enterprise creation), which would underscore policy relevance.  
   - Consider whether delayed transposition also affects the quality or survival of firms once they enter. Even though active firms are unchanged, the paper could speculate on longer-term consequences (investment, growth) to motivate future work.

5. **Communicate standard errors and inference clearly.**  
   - Since the paper relies on 20 clusters, emphasize the wild cluster bootstrap results in the main table or add a panel showing bootstrap p-values.  
   - When presenting interaction effects (Table 6), report both the base effect and the interaction standard errors, and consider plotting predicted values for regulated vs. non-regulated sectors to aid interpretation.

By addressing these points—particularly tightening the identification, clarifying the treatment mapping, and enriching robustness—the paper will substantively improve its claim that transposition delay harms firm entry through regulatory uncertainty, and it will be better positioned for publication in AER: Insights.
